title: Chimeric GABAA/glycine receptors: expression and barbiturate pharmacology.
abstract: GABAA and glycine receptors are close relatives in the "gene superfamily" of ligand-gated ion channels, but have distinctly different pharmacology. For example, barbiturates have two effects on GABAA receptors (GABAA-R): at low micromolar concentrations (2-5 microM), the anesthetic barbiturate methohexital potentiates submaximal chloride current responses to GABA; at higher concentrations (20-50 microM), the barbiturate causes direct gating of the channel in the absence of agonist. Neither of these barbiturate effects is seen on the glycine receptor (Gly-R). In order to study the structural parts of the GABAA-R involved in this barbiturate pharmacology, two unique restriction sites were introduced into the cDNAs encoding the alpha 2 and beta 1 subunits of the human GABAA-R and the alpha 1 subunit of the human gly-R. The first site ('X') corresponded to the C-terminal end of the third transmembrane domain (M3) in each subunit and enabled exchange of C-terminal fragment of approximately 100 amino acids (which includes the large 'cytoplasmic loop' and M4 segment) between GABAA-R and Gly-R subunits. The second site ('S') was approximately 30 amino acids 3'- from the N-terminal end of each subunit and enabled exchange of a small N-terminal fragment between GABAA-R and Gly-R subunits. Several chimeric receptor subunit cDNAs were constructed and the resulting receptors tested for their ability to respond to GABA and glycine and for sensitivity to the barbiturate methohextial (MTX). The results show that neither the large C-terminal fragment nor the smaller N-terminal fragment is associated with the enhancement or direct activation of the GABAA-R by MTX. These results demonstrate the viability of chimeric GABAA/Gly-R and suggest that the method will be suitable for further investigation of the molecular basis of the barbiturate pharmacology of the GABA-R.
authors.affiliation: Department of Pharmacological and Physiological Sciences, University of Chicago, IL 60637, USA.
authors.forename: V V
authors.initials: VV
authors.lastname: Koltchine
authors.forename: Q
authors.initials: Q
authors.lastname: Ye
authors.forename: S E
authors.initials: SE
authors.lastname: Finn
authors.forename: N L
authors.initials: NL
authors.lastname: Harrison
mesh_terms: D018681:Anesthetics, General / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology*; D002478:Cells, Cultured; D004247:DNA / Q000096:biosynthesis; D004594:Electrophysiology; D005998:Glycine / Q000494:pharmacology; D006801:Humans; D008564:Membrane Potentials / Q000187:drug effects; D008723:Methohexital / Q000494:pharmacology; D016297:Mutagenesis, Site-Directed; D015345:Oligonucleotide Probes / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D011963:Receptors, GABA-A / Q000096:biosynthesis* / Q000187:drug effects / Q000235:genetics*; D018009:Receptors, Glycine / Q000187:drug effects / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis* / Q000235:genetics*; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
chemical_list: D018681:Anesthetics, General; D001463:Barbiturates; D015345:Oligonucleotide Probes; D011963:Receptors, GABA-A; D018009:Receptors, Glycine; D011993:Recombinant Fusion Proteins; D005680:gamma-Aminobutyric Acid; D004247:DNA; D008723:Methohexital; D005998:Glycine